The Bcl-2 family of proteins includes key regulators of apoptosis (reviewed in [1, 2] ), some of which promote cell death while others prevent it. The observation that the Bcl-2 family regulates the release of pro-apoptotic proteins from mitochondria led to the concept that members of the family control cell survival by regulating the permeability of these organelles [3, 4] . Several models explain how this regulation might be achieved (reviewed in [5] ). One of the models comes from the intriguing observation that the tertiary structure of Bcl-2 proteins resembles that of colicins and diphtheria toxin (DT) [6] .
Colicins are toxins made by bacteria to kill other bacterial strains (reviewed in [7] ). Colicins contain three domains: the receptor binding, the translocation and the toxic domain. Bcl-2 proteins are similar in structure to the toxic domains, that kill by making pores in the bacterial membrane. Perforation dissipates ion gradients, which leads to the release of essential metabolites, the influx of water and cell rupture. This structural similarity suggested that Bcl-2 proteins might function by making pores in mitochondrial membranes (reviewed in [5, 8] ). Although some Bcl-2 proteins can indeed form pores in synthetic lipid membranes, the model faces substantial challenges (reviewed in [2] ). For example, the structures of Bax and Bcl-x are remarkably similar [9] , suggesting that if one of the proteins makes the pores, the other would likely make them as well. Yet Bax promotes the release of pro-apoptotic molecules from mitochondria, whereas Bcl-x prevents it. This puzzle has not been made easier by the difficulty to explain how Bcl-x or Bcl-2 could prevent release of proteins from mitochondria by making pores. These and other unexplained observations argue that either the similarity between the Bcl-2 family and the toxins is a coincidence, or they share a common function unrelated to the formation of pores. I would like to argue in favor of the second possibility by exploring the homology of the Bcl-2-like proteins to diphtheria toxin.
Diphtheria toxin kills human cells by a mechanism that is different from that employed by colicins to kill bacteria. DT belongs to the AB family of toxins, which includes bacterial and plant toxins that are made of two moieties: A and B (reviewed in [10] ). The A moieties are usually enzymes that are toxic to the cell. For example, the A moiety of DT is an ADP-ribosyl transferase that kills by inactivating an elongation factor required for protein synthesis. The B moieties, whose structures vary, translocate the A moieties through cell membranes. The B moiety of DT contains a receptor binding domain, which binds a specific cell surface receptor, and a translocation domain.
How does the A moiety of DT enter the cytoplasm? Although the translocation of DT has been extensively studied, the exact mechanism remains unclear. The current view is that binding of DT to its receptor leads to endocytosis of the complex. The acidic environment of the endosome apparently triggers a conformational change in the translocation domain. This change leads to insertion of the B moiety into the endosomal membrane, and the concomitant translocation of the A moiety into the cytoplasm. The sulfhydryl bond linking the A and B moieties is reduced in the cytoplasm, freeing the A moiety. Importantly, although the translocation of DT is accompanied by formation of cation-selective channels, it is unclear whether the R734 Current Biology Vol 11 No 19 channels are required for the translocation. For example, a modified DT can translocate the A moiety without forming any detectable channels [11] . In contrast to the pores formed by colicins, channels formed by DT are not sufficient to kill the cell. Even models that consider the channels to be related to toxin translocation do not argue that the A moiety simply floats through the channel but rather suggest that the B moiety functions as a chaperone that unfolds the A moiety to pass it through the channel [10] . Hence, one can argue that the main function of the B moiety is to translocate the A moiety through a cell membrane. Therefore, I would like to propose that the structural similarity between the Bcl-2 proteins and the DT translocation domain indicates that the common function of these proteins is to translocate other molecules or themselves through membranes, rather than to form pores.
The hypothesis that Bcl-2-like proteins are protein translocators would be pure conjecture if not for direct evidence that at least some of these proteins can substitute for the translocation domain of DT. This evidence comes from the laboratory of Richard Youle, who developed an approach to deliver Bcl-x into cells [12] . Youle and colleagues replaced the translocation domain of DT with Bcl-x, reasoning that Bcl-x may translocate itself into the cytoplasm if the homology between the proteins is functional. Indeed the hybrid protein which contained Bcl-x fused to the DT receptor-binding domain not only efficiently translocated through the cell membrane but also protected cells from apoptosis. These experiments provide direct evidence that Bcl-x not only structurally resembles but also functions like the translocation domain of DT, although whether the hybrid protein can translocate proteins other than itself has not been tested.
What would the Bcl-2-like proteins translocate? The intriguing feature of the toxins is that the A and B moieties do not necessarily need to be covalently linked to complete the translocation. For example, the B moiety of the anthrax toxin translocates either of the toxin's two A moieties without forming a covalent bond [10] . Another intriguing observation is that the B moieties can translocate proteins unrelated to toxins [13] . Therefore, in principle, any proteins or other molecules that can bind to Bcl-2 can be translocated. One possibility is that the pro-apoptotic proteins are translocated directly. Alternatively the release may be a consequence of the Bcl-2 family functioning as translocators to create gradients of proteins, including gradients of themselves, or of other molecules.
How would the translocation be regulated? Toxin translocation is triggered by the acidic environment, which changes the toxin conformation. Perhaps a change in conformation of the Bcl-2 proteins may be regulated by other factors, as was reported for Bax [9] . Do the Bcl-2 proteins function alone or as a part of a protein complex? An answer to this question may come from the observation that when the transmembrane domain of Bax was replaced with that of Bcl-xL the chimeric protein failed to promote apoptosis, even though it bound to mitochondria [14] . One can surmise that the transmembrane domain is more than a membrane anchor, as is often assumed, but rather is a specific receptor-binding domain. This would suggest that the similarity between Bcl-2 and the DT B-moiety goes beyond the translocation domain. The existence of receptors for Bcl-2-like proteins may imply that these proteins function as protein complexes, or in complexes with other molecules.
In summary, this letter proposes that the Bcl-2 family, like diphtheria toxin, function as transmembrane translocators.
